According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ1.40. In 2025 the company made an earnings per share (EPS) of -ยฃ0.58 an increase over its 2024 EPS that were of -ยฃ0.77.